January 28, 2021

Group 1 Automotive’s Debt Overview

Over the past three months, shares of Group 1 Automotive (NYSE: GPI) increased by 57.98%. Before we understand the importance of debt, let us look at how much debt Group 1 Automotive has.

Group 1 Automotive’s Debt

According to the Group 1 Automotive’s most recent balance sheet as reported on August 3, 2020, total debt is at $2.47 billion, with $1.36 billion in long-term debt and $1.11 billion in current debt. Adjusting for $72.70 million in cash-equivalents, the company has a net debt of $2.40 billion.

To understand the degree of financial leverage a company has, shareholders look at the debt ratio. Considering Group 1 Automotive’s $4.86 billion in total assets, the debt-ratio is at 0.51. As a rule of thumb, a debt-ratio more than one indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself

Read More

Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has completed its at-the-market (ATM) offering program initiated during the third quarter, generating gross proceeds of $50.0 million. Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc. acted as placement agents for the offering.

In addition, Bicycle announced that it has closed a financing with Hercules Capital, Inc. (NYSE: HTGC) for a term loan of up to $40.0 million in two tranches. Under the terms of the loan and security agreement, an initial tranche of $30.0 million will be fully available at the loan closing, with a minimum draw of $15.0 million.

“I am pleased to announce the successful utilization of our ATM program and our flexible financing with Hercules, which have further

Read More